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Edited by Sandro SonninoAbstract Cellular levels of the phosphoinositide PtdIns5P are
regulated by agonist stimulation, but the mechanisms controlling
turnover of this lipid, and the subcellular location of the regu-
lated PtdIns5P pool(s), remain poorly understood. Here we show
that enhanced tyrosine phosphorylation robustly increases cellu-
lar PtdIns5P levels. Moreover, unlike PtdIns5P production en-
hanced by cell stress, we show that this pool of PtdIns5P is
speciﬁcally regulated by the inositol lipid kinase PIP4K2a.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The phosphoinositides are lipids that play pivotal roles in
many cellular processes by interacting with distinct binding
proteins. Much is known about the functions of certain phos-
phoinositides, such as the multifunctional lipid PtdIns(4,5)P2,
but others, notably the poorly-characterised PtdIns5P, are
far less well understood. Available evidence suggests that
PtdIns5P mediates cellular signalling: various stimuli increase
PtdIns5P levels [1–4] and PtdIns5P generated in the nucleus
in response to DNA-damaging agents regulates p53 [4–6]. Nu-
clear PtdIns5P is removed by the lipid kinase PIP4K2b (also
known as type IIb PIP kinase), which converts PtdIns5P to
PtdIns(4,5)P2 [4].
Although several studies indicate an important nuclear role
for PtdIns5P, other evidence suggests it also functions else-
where in the cell. Firstly, PtdIns5P is present in anucleate
platelets [1], and facilitates cortical actin rearrangements in
insulin-stimulated adipocytes [2]. Additionally, infection with
Shigella ﬂexneri promotes plasma membrane PtdIns5P pro-
duction [7,8] through the action of a bacterial PtdIns(4,5)P2
4-phosphatase, resulting in PI 3-kinase activation [8]. More-
over, as well as PIP4K2b, mammals have two further PIP4Ks,
PIP4K2a and PIP4K2c (also known, respectively, as type IIa
and type IIc PIP kinase), neither of which is nuclear [9–11],
suggesting that they regulate PtdIns5P at distinct subcellular
locations. To investigate the role of PIP4Ks in PtdIns5P regu-Abbreviations: PtdIns, phosphatidylinositol; PV, pervanadate; RNAi,
RNA interference
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doi:10.1016/j.febslet.2008.03.022lation, we have used RNA interference (RNAi) to knock down
individual isoforms, and investigated the impact of this on
PtdIns5P generation in response to activation of tyrosine ki-
nase signalling. Here we show that depleting PIP4K2a, but
not PIP4K2b or 2c, signiﬁcantly enhances stimulated PtdIns5P
production, consistent with a role for PIP4K2a in controlling a
distinct, tyrosine-kinase regulated pool of PtdIns5P.2. Materials and methods
2.1. Cell culture and stimulation
HeLa S3 cells were cultured as described [9]. Pervanadate (PV) was
prepared by mixing equal volumes of 100 mM Na3VO4 (Sigma) and
100 mM hydrogen peroxide (H2O2; Sigma). Residual H2O2 was re-
moved by incubation with catalase (200 lg ml1).
2.2. Transfection
Cells were transfected with 5-50 nM HP GenomeWide siRNA (Qia-
gen) using HiPerfect (Qiagen) according to the manufacturers instruc-
tions. Eﬀects were optimal with 10 nM siRNA, 3 days post-
transfection. Transfection with cDNAs was carried out by nucleofec-
tion (Amaxa).
2.3. q-RT-PCR
RNA was extracted with the Absolutely RNA Miniprep Kit (Strat-
agene), and reverse-transcribed with the High Capacity cDNA Reverse
Transcription Kit (Applied Biosytems); cDNA was mixed with Power-
SYBR Green PCR Mastermix (Applied Biosystems) and QuantiTect
Primer Assay primers (Qiagen). Ampliﬁcations were performed in trip-
licate in an ABI 7500 sequence detection system (Applied Biosystems).
Relative quantiﬁcation was carried out using the ddCt method, norma-
lised to GAPDH expression.
2.4. Protein extraction and analysis
Due to the low sensitivity of the speciﬁc antibody used, PIP4K2a
was immunoprecipitated before Western blotting. Cells were lysed in
ice-cold immunoprecipitation buﬀer (10 mM HEPES, pH 7.4,
150 mM NaCl, 1% Triton X-100, 5 mM EDTA, 1 mM AEBSF,
1 lg ml1 leupeptin), and 200 lg protein (quantiﬁed by BCA Protein
Assay (Pierce)) immunoprecipitated with antibody MAC334 (which
recognises PIPK2a and PIPK2b), as described [12]. For PIPK2b anal-
ysis, cells were lysed in ice-cold RIPA buﬀer (10 mM Tris, pH7.2,
150 mM NaCl, 1%NP40, 0.5% sodium deoxycholate, 0.1% SDS,
5 mM EDTA 1 mM AEBSF, 1 lg ml1 leupeptin). Proteins were sep-
arated by SDS–PAGE, transferred to PVDF, and PIP4Ks detected
using the antibodies AP8041b or AP8042b (Abgent; for PIP4K2a or
2b, respectively). Actin was detected in cell lysates or immunoprecipi-
tation supernatants with antibody SC-1616R (Santa Cruz Biotechnol-
ogy). HRP-conjugated second antibodies were from Dako; blots were
visualised using enhanced chemiluminescence (Pierce).
2.5. Lipid extraction and PtdIns5P mass assay
Lipidswere extractedasdescribedbyHalsteadet al. [13], andPtdIns5P
assayed as previously described [14], by conversion to 32P-labelledblished by Elsevier B.V. All rights reserved.
A1392 A. Wilcox, K.A. Hinchliﬀe / FEBS Letters 582 (2008) 1391–1394PtdIns(4,5)P2, which was quantiﬁed by phosphoimaging. Statistical
analysis (one-way ANOVA with Tukeys Multiple Comparison Test)
was performed using GraphPad Prism.Na3VO4
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Fig. 1. Characterisation of PtdIns5P production in response to PV.
(A) HeLa S3 cells were incubated with or without 500 lM PV for
20 min, and PtdIns5P assayed. Autoradiographs of the radiolabelled
PtdIns(4,5)P2 derived from this PtdIns5P are shown, demonstrating
that the amount of PtdIns5P is markedly increased in cells exposed to
PV. (B) To investigate the contribution of PV, and of its constituents,
to the PtdIns5P response, cells were incubated with sodium orthovan-
adate, H2O2, or PV (all 500 lM) for 20 min, with or without catalase
pre-treatment, and PtdIns5P levels assayed. Results (the mean-
s ± S.E.M. of 3–9 independent experiments) are expressed relative to
PtdIns5P levels in untreated cells. (C) Incubation of cells with AG213
for 1 h prior to catalase-treated PV addition (500 lM; 20 min) inhibits
the stimulated production of PtdIns5P. Results are expressed relative
to vehicle (dimethylsulfoxide)-treated controls (n = 6). In cells pre-
treated with 1 mM AG213, the response to PV is not signiﬁcantly
greater than control.3. Results and discussion
Few stimuli provoking robust PtdIns5P increases have yet
been identiﬁed, possibly reﬂecting the fact that PtdIns5P
changes are usually modest [1,2,4], and are superimposed on
signiﬁcant resting PtdIns5P levels. We screened a variety of
agonists for simulated PtdIns5P production in HeLa S3 cells,
but did not identify any producing a robust response ([14]
and data not shown). However, the ability of tyrosine kinase
activation to generate PtdIns5P in certain systems [2,15] sug-
gested that the phospho-tyrosine phosphatase inhibitor PV,
which enhances tyrosine phosphorylation levels and has been
widely used as an insulin-mimetic [16], might increase
PtdIns5P production. In agreement with this idea, we found
that PV markedly increased both tyrosine phosphorylation
(not shown), and PtdIns5P (Fig. 1A). However, PV is pro-
duced by mixing H2O2 and orthovanadate, and H2O2 increases
nuclear PtdIns5P [4], so we next determined whether either
constituent of PV alone could aﬀect PtdIns5P. Orthovanadate
modestly, and H2O2 markedly, increase PtdIns5P (Fig. 1B),
and pre-treatment of H2O2 with the peroxidase catalase abol-
ished H2O2-stimulated PtdIns5P production. Importantly,
however, although catalase reduced the response to PV, pre-
sumably through residual H2O2 removal, it did not abolish
the response entirely, suggesting a distinct eﬀect of PV on
PtdIns5P production.
Next, we investigated whether tyrosine kinase signalling
underlay the stimulation of PtdIns5P production by PV, by
pre-treatment with the tyrosine kinase inhibitor AG213 before
catalase-treated PV addition. AG213 dose-dependently inhib-
ited PV-stimulated PtdIns5P increases (Fig. 1C), without
aﬀecting basal PtdIns5P, consistent with the eﬀect being due
to tyrosine kinase activity. A major problem besetting
PtdIns5P research is the fact that stimulated changes in its con-
centration are relatively modest. Catalase-treated PV elevated
PtdIns5P approximately 2.8-fold, a response of similar magni-
tude to that seen with physiological agonists [1,2]. This robust
response thus provides a useful method for investigating the
regulation of PtdIns5P by stimuli that activate tyrosine kinase
signalling. To investigate regulation of the PV-stimulated
PtdIns5P pool further, all subsequent experiments were carried
out using catalase-treated PV.
We next investigated the impact of selective knockdown of
PIP4K2s on the response, using RNAi. RNAi knocked down
individual PIP4K expression at both the mRNA (Fig. 2A)
and protein levels (Fig. 2B; though note that antibodies for
PIP4K2c analysis were not available). Interestingly, knock-
down of PIP4K2a, but not 2b or 2c, markedly augmented
the PV response (Fig. 2C), suggesting that the PV-stimulated
PtdIns5P pool is regulated speciﬁcally by PIP4K2a, which con-
verts the lipid to PtdIns(4,5)P2. The other PIP4Ks are evi-
dently unable to target the PV-regulated PtdIns5P pool,
probably due to their diﬀerent subcellular localisations.
PIP4K2b is largely nuclear [9,10], and regulates a discrete nu-
clear PtdIns5P pool [4,5], whilst PIP4K2c is associated with
the endoplasmic reticulum [11], and PIP4K2a is cytosolic.
Clearly the cytoplasm is unlikely to be the location of its lipidsubstrate, but several reports suggest that PIP4K2a is recruited
to particulate cellular fractions upon stimulation [12,17]: such
interaction with other proteins or membranes presumably
facilitates its interaction with PtdIns5P.
We were unable to establish the subcellular location of the
PV-stimulated PtdIns5P pool, as PV did not alter the cytosolic
distribution of GFP-tagged PIP4K2a (not shown), and we
could not ascertain the localisation of endogenous PIP4K2a
due to the unsuitability of available antibodies for immunocy-
tochemistry. However, PV does not cause PIP4K2a to migrate
into the nucleus (not shown), further supporting the idea that
the PIP4K2a-regulated PtdIns5P pool is not nuclear. Previous
studies that have attempted to reduce PtdIns5P using PIP4Ks
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Fig. 2. RNAi knockdown of PIP4K isoforms and its eﬀects on PV-
stimulated PtdIns5P production. Cells were treated with siRNAs
against the three mammalian PIP4Ks, PIP4K2a, 2b and 2c, or with a
non-speciﬁc siRNA (control). The speciﬁc siRNAs signiﬁcantly
reduced expression of these genes at the mRNA level (A: quantiﬁed
by q-RT-PCR) and, for PIP4K2a and 2b, the protein level (B:
determined by Western blotting). Arrows indicate the bands corre-
sponding to PIP4K2a and PIP4K2b; actin loading controls are also
shown. The eﬀect of knockdown of individual PIP4Ks on PV-
stimulated PtdIns5P production was also examined (C). Speciﬁc
knockdown of PIP4K2b or 2c was without eﬀect on the ability of
catalase-treated PV to increase PtdIns5P, compared with cells treated
with a non-speciﬁc control siRNA. However, the response was
signiﬁcantly increased (P < 0.001; n = 6) in cells treated with siRNA
targeting PIP4K2a.
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Fig. 3. PIP4K2a overexpression reduces the response to PV. Cells were
transfected with GFP, or with GFP-tagged versions of wild-type or
kinase-dead (D273K) PIP4K2a. Twenty-four hours post-transfection,
cells were incubated with or without catalase-treated PV (500 lM) for
20 min, and PtdIns5P measured. Transfection with wild-type PIP4-
K2a, but not with the D273K mutant, signiﬁcantly reduced the
response (P < 0.05). Results are means ± S.E.M., n = 6.
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Fig. 4. Eﬀect of PtdIns(4,5)P2 4-phosphatase knockdown. Transfec-
tion with siRNA targeting type I PtdIns(4,5)P2 4-phosphatase did not
signiﬁcantly aﬀect the response to PV. The type I-speciﬁc siRNA
reduced expression by 80–90% at the mRNA level. Type II
PtdIns(4,5)P2 4-phosphatase mRNA is barely detectable in HeLa S3
cells. Results are means ± S.E.M., n = 3.
A. Wilcox, K.A. Hinchliﬀe / FEBS Letters 582 (2008) 1391–1394 1393have used PIP4K2b for this purpose. However, although
PIP4K2b is present outside the nucleus when overexpressed
[9], the endogenous protein is largely restricted to this orga-
nelle [10], and our results suggest that overexpression of PIP4-
K2a would be more appropriate for manipulation of PtdIns5P
production in response to tyrosine kinase signalling.
To determine whether PIP4K2a negatively regulates PV-
stimulated PtdIns5P production, we next investigated the eﬀect
of its overexpression on PtdIns5P production. Consistent with
the ability of PIP4K2a to target PV-stimulated PtdIns5P, we
found that overexpressing the wild-type enzyme, but not the
kinase-dead D273K mutant [18], signiﬁcantly reduced the
PV-stimulated PtdIns5P increase (Fig. 3). Localisation of the
D273K mutant is indistinguishable from that of the wild-type
enzyme (not shown).Stimulation of nuclear PtdIns5P production by DNA-dam-
aging agents is caused by nuclear recruitment of the cytosolic
protein type I PtdIns(4,5)P2 4-phosphatase [5]. To investigate
whether this protein is responsible for PV-stimulated PtdIns5P
production, we used RNAi to knock down its expression, but
this had no eﬀect on the response to PV (Fig. 4). This suggests
that oxidative stress and PVmay generate PtdIns5P by diﬀerent
routes. Cell stress increases nuclear PtdIns5P through type I
PtdIns(4,5)P2 4-phosphatase activation [5], but our results sug-
gest that this pathway is not responsible for PV-stimulated
PtdIns5P generation. Instead, PV may stimulate PtdIns5P pro-
duction via a distinct mechanism, possibly phosphorylation of
PtdIns by PIKfyve [19], or dephosphorylation of PtdIns(3,5)P2
by myotubularins [3]. Resolution of this question, and that of
the subcellular location of the PIP4K2a-regulated PtdIns5P
pool, remains a priority of our future research.
Acknowledgements: This work was funded by the BBSRC. We thank S.
Al-Ahdab and D. Grainger for critical reading of the manuscript.References
[1] Morris, J.B., Hinchliﬀe, K.A., Ciruela, A., Letcher, A.J. and
Irvine, R.F. (2000) Thrombin stimulation of platelets causes an
1394 A. Wilcox, K.A. Hinchliﬀe / FEBS Letters 582 (2008) 1391–1394increase in phosphatidylinositol 5-phosphate revealed by mass
assay. FEBS Lett. 475, 57–60.
[2] Sbrissa, D., Ikonomov, O.C., Strakova, J. and Shisheva, A. (2004)
Role for a novel signaling intermediate, phosphatidylinositol 5-
phosphate, in insulin-regulated F-actin stress ﬁber breakdown
and GLUT4 translocation. Endocrinology 145, 4853–4865.
[3] Tronchere, H., Laporte, J., Pendaries, C., Chaussade, C., Liaubet,
L., Pirola, L., Mandel, J.L. and Payrastre, B. (2004) Production of
phosphatidylinositol 5-phosphate by the phosphoinositide 3-
phosphatase myotubularin in mammalian cells. J. Biol. Chem.
279, 7304–7312.
[4] Jones, D.R., Bultsma, Y., Keune, W.J., Halstead, J.R., Elouarrat,
D., Mohammed, S., Heck, A.J., DSantos, C.S. and Divecha, N.
(2006) Nuclear PtdIns5P as a transducer of stress signaling: an
in vivo role for PIP4Kbeta. Mol. Cell 23, 685–695.
[5] Zou, J., Marjanovic, J., Kisseleva, M.V., Wilson, M. and
Majerus, P.W. (2007) Type I phosphatidylinositol-4,5-bisphos-
phate 4-phosphatase regulates stress-induced apoptosis. Proc.
Natl. Acad. Sci. USA 104, 16834–16839.
[6] Gozani, O., Karuman, P., Jones, D.R., Ivanov, D., Cha, J.,
Lugovskoy, A.A., Baird, C.L., Zhu, H., Field, S.J., Lessnick, S.L.,
Villasenor, J., Mehrotra, B., Chen, J., Rao, V.R., Brugge, J.S.,
Ferguson, C.G., Payrastre, B., Myszka, D.G., Cantley, L.C.,
Wagner, G., Divecha, N., Prestwich, G.D. and Yuan, J. (2003)
The PHD ﬁnger of the chromatin-associated protein ING2
functions as a nuclear phosphoinositide receptor. Cell 114, 99–
111.
[7] Niebuhr, K., Giuriato, S., Pedron, T., Philpott, D.J., Gaits, F.,
Sable, J., Sheetz, M.P., Parsot, C., Sansonetti, P.J. and Payrastre,
B. (2002) Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.
ﬂexneri eﬀector IpgD reorganizes host cell morphology. EMBO J.
21, 5069–5078.
[8] Pendaries, C., Tronchere, H., Arbibe, L., Mounier, J., Gozani, O.,
Cantley, L., Fry, M.J., Gaits-Iacovoni, F., Sansonetti, P.J. and
Payrastre, B. (2006) PtdIns5P activates the host cell PI3-kinase/
Akt pathway during Shigella ﬂexneri infection. EMBO J. 25,
1024–1034.
[9] Ciruela, A., Hinchliﬀe, K.A., Divecha, N. and Irvine, R.F. (2000)
Nuclear targeting of the beta isoform of type II PIP kinase by
alpha helix-7. Biochem. J. 346, 587–591.
[10] Richardson, J.P., Wang, M., Clarke, J.H., Patel, K.J. and Irvine,
R.F. (2007) Genomic tagging of endogenous type IIbeta phos-phatidylinositol 5-phosphate 4-kinase in DT40 cells reveals a
nuclear localisation. Cell. Signal. 19, 1309–1314.
[11] Itoh, T., Ijuin, T. and Takenawa, T. (1998) A novel phosphati-
dylinositol-5-phosphate 4-kinase (phosphatidylinositol-phosphate
kinase IIc) is phosphorylated in the endoplasmic reticulum in
response to mitogenic signals. J. Biol. Chem. 273, 20292–20299.
[12] Hinchliﬀe, K.A., Irvine, R.F. and Divecha, N. (1996) Aggrega-
tion-dependent, integrin-mediated increases in cytoskeletally
associated PtdInsP2 (4,5) levels in human platelets are controlled
by translocation of PtdIns 4-P 5-kinase C to the cytoskeleton.
EMBO J. 15, 6516–6524.
[13] Halstead, J., Roefs, M., Ellson, C.D., DAndrea, S., Chen, C.,
DSantos, C.S. and Divecha, N. (2001) A novel pathway of
cellular phosphatidylinositol(3,4,5)-trisphosphate synthesis is reg-
ulated by oxidative stress. Curr. Biol. 11, 386–395.
[14] Roberts, H.F., Clarke, J.H., Letcher, A.J., Irvine, R.F. and
Hinchliﬀe, K.A. (2005) Eﬀects of lipid kinase expression and
cellular stimuli on phosphatidylinositol 5-phosphate levels in
mammalian cell lines. FEBS Lett. 579, 2868–2872.
[15] Carricaburu, V., Lamia, K.A., Lo, E., Favereaux, L., Payrastre,
B., Cantley, L.C. and Rameh, L.E. (2003) The phosphatidylin-
ositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin
signaling by regulating PI-3,4,5-trisphosphate degradation. Proc.
Natl. Acad. Sci. USA 100, 9867–9872.
[16] Heﬀetz, D., Bushkin, I., Dror, R. and Zick, Y. (1990) The
insulinomimetic agents H2O2 and vanadate stimulate protein
tyrosine phosphorylation in intact cells. J. Biol. Chem. 265, 2896–
2902.
[17] Hinchliﬀe, K.A., Giudici, M.L., Letcher, A.J. and Irvine, R.F.
(2002) Type IIalpha phosphatidylinositol phosphate kinase asso-
ciates with the plasma membrane via interaction with type I
isoforms. Biochem. J. 363, 563–570.
[18] Sbrissa, D., Ikonomov, O.C., Deeb, R. and Shisheva, A. (2002)
Phosphatidylinositol 5-phosphate biosynthesis is linked to PIK-
fyve and is involved in osmotic response pathway in mammalian
cells. J. Biol. Chem. 277, 47276–47284.
[19] Rozenvayn, N. and Flaumenhaft, R. (2003) Protein kinase C
mediates translocation of type II phosphatidylinositol 5-phos-
phate 4-kinase required for platelet alpha-granule secretion. J.
Biol. Chem. 278, 8126–8134.
